![Frontiers | Born to be Alive: A Role for the BCL-2 Family in Melanoma Tumor Cell Survival, Apoptosis, and Treatment | Oncology Frontiers | Born to be Alive: A Role for the BCL-2 Family in Melanoma Tumor Cell Survival, Apoptosis, and Treatment | Oncology](https://www.frontiersin.org/files/Articles/14268/fonc-01-00034-HTML/image_m/fonc-01-00034-g001.jpg)
Frontiers | Born to be Alive: A Role for the BCL-2 Family in Melanoma Tumor Cell Survival, Apoptosis, and Treatment | Oncology
![Biomolecules | Free Full-Text | The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms | HTML Biomolecules | Free Full-Text | The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms | HTML](https://www.mdpi.com/biomolecules/biomolecules-10-00128/article_deploy/html/images/biomolecules-10-00128-g001.png)
Biomolecules | Free Full-Text | The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms | HTML
![NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death | PNAS NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death | PNAS](https://www.pnas.org/cms/10.1073/pnas.1806928115/asset/048aa907-ed37-4a82-9d51-9d809bec0b25/assets/graphic/pnas.1806928115fig06.jpeg)
NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death | PNAS
![Role of Bcl‐2 family proteins in apoptosis: apoptosomes or mitochondria? - Tsujimoto - 1998 - Genes to Cells - Wiley Online Library Role of Bcl‐2 family proteins in apoptosis: apoptosomes or mitochondria? - Tsujimoto - 1998 - Genes to Cells - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a69358a4-16c3-4e70-a22b-46fc2571ce36/gtc_223_f2.gif)
Role of Bcl‐2 family proteins in apoptosis: apoptosomes or mitochondria? - Tsujimoto - 1998 - Genes to Cells - Wiley Online Library
![A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy | Cell Death & Disease A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fcddis.2010.18/MediaObjects/41419_2010_Article_BFcddis201018_Fig1_HTML.jpg)
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy | Cell Death & Disease
![TARGETING THE ANTI-APOPTOTIC BCL-2 FAMILY MEMBERS FOR THE TREATMENT OF CANCER | Experimental oncology TARGETING THE ANTI-APOPTOTIC BCL-2 FAMILY MEMBERS FOR THE TREATMENT OF CANCER | Experimental oncology](http://exp-oncology.com.ua/uploads/2012/09/wpid-1174_01_fmt.jpeg)